fb-pixelscorecardresearch
www.fgks.org   »   [go: up one dir, main page]
Skip to main content
Health and biotech

Latest stories

At Senate hearing, Bernie Sanders grills Moderna CEO for quadrupling COVID vaccine price
Moderna has previously said it will make its COVID shots freely available to anyone without insurance, but senators were skeptical about how that would work.
State officials issue guidance to Mass. pharmacies: stock abortion pills
Officials said Mass. pharmacies must stock all reproductive health medications including mifepristone, a drug that can safely end a pregnancy in its early stages.
Can light reset brainwaves to treat Alzheimer’s? This Boston startup has $73 million to find out.
Cognito Therapeutics has started an advanced clinical study of its experimental device based on groundbreaking research at MIT.
Troubled US organ transplant system targeted for overhaul
If successful, the overhaul would leave little unaffected in the sprawling, multibillion-dollar network that sends kidneys, livers and other organs from deceased donors to severely ill recipients.
innovation beat
Boston startup uses AI to untangle health insurance problems
CodaMetrix’s software is designed to speed up the reimbursement process and cut down on the many frustrating denials.
Beth Teitell | Commentary
First came the weight loss. Then came the drama around Ozempic.
Ozempic started life as a drug to treat Type 2 diabetes. But ever since Hollywood and TikTok discovered it was a miracle weight loss treatment, things have gotten intense.
Featured stories
How a Boston doctor diagnosed the first US case of monkeypox
After a few days, the doctor noticed a telling change. The patient’s rash consisted of fluid-filled blisters that had a dent in the center. His rash looked like smallpox.
Once the ‘it’ supplement, vitamin D is losing its sparkle
Vitamin D supplements, regularly consumed by millions of Americans, have not held up to the considerable hype of warding off many common, dreaded diseases.
Right-wing groups hit Boston Children’s with barrage of threats over trans health program
A hostile online campaign has prompted the hospital to seek help from law enforcement.
This startup aims to delay menopause and prolong fertility with a new contraceptive
Oviva Therapeutics just raised $11.5 million to develop drugs based on the work of Mass. General researchers.
Biotech
At Senate hearing, Bernie Sanders grills Moderna CEO for quadrupling COVID vaccine price
Moderna has previously said it will make its COVID shots freely available to anyone without insurance, but senators were skeptical about how that would work.
Can light reset brainwaves to treat Alzheimer’s? This Boston startup has $73 million to find out.
Cognito Therapeutics has started an advanced clinical study of its experimental device based on groundbreaking research at MIT.
Boston scientists say they’re a step closer to growing human eggs in the lab
George Church’s lab at the Wyss Institute of Harvard is one of a handful around the globe trying to coax adult stem cells, derived from blood or skin, to become human eggs capable of forming an embryo.
Lifestyle
Troubled US organ transplant system targeted for overhaul
If successful, the overhaul would leave little unaffected in the sprawling, multibillion-dollar network that sends kidneys, livers and other organs from deceased donors to severely ill recipients.
INNOVATOR Q&AWhat are the health consequences astronauts face when launching into space?
A University of Rhode Island researcher is working on easing the havoc the lack of gravity has on the muscular, skeletal, and metabolic systems in space.
RI HEALTHUp to 30,000 people could lose Medicaid coverage, R.I. health officials say
The Medicaid renewal and eligibility determination will only affect health insurance coverage, but will not impact other benefits like the Supplemental Nutrition Assistance Program.
Spotlight
How Brigham Health helped create a Chinese hospital for elites — and almost nobody came
In a deal worth millions with Chinese developer Evergrande, a Harvard teaching hospital risked its reputation on what would become a near-empty shell.
Boston’s hospital chiefs moonlight on corporate boards at rates far beyond the national level
Hospital chiefs and trustees defend this as boosting public-private partnerships, but critics say these board positions — some paying millions of dollars — raise troubling issues of conflict of interest and hospital priorities.

More biotech and health care stories

Hospitals plead for flexibility on spending amid soaring costs of temporary nurses

Massachusetts hospitals spent $1.5 billion on temporary labor in 2022, up 610 percent over 2019.

Company offering new AI body scans slated to open in Mass. Experts warn about cost, false positives.

Some experts are concerned that these new body scans for the “worried well” are surging ahead of the current science on AI.

INNOVATOR Q&A

What are the health consequences astronauts face when launching into space?

A University of Rhode Island researcher is working on easing the havoc the lack of gravity has on the muscular, skeletal, and metabolic systems in space.

Three years after COVID-19 was declared a pandemic, how cautious are the experts?

Some say they’ve loosened up, at least in their personal lives, but there are things they’re still keeping an eye on.

Tick-borne disease babesiosis now considered endemic in northern New England

Most cases are transmitted to humans by bites from blacklegged ticks also known as deer ticks, the same insects that carry Lyme disease.

‘Bringing the treatment to where they are.’ Mobile health vans have boomed since the pandemic.

First, they helped close COVID-19 vaccination gaps. Now they’re tackling chronic diseases and mental illness.

Medical residents at Mass General Brigham could soon unionize. Here’s why.

The health system is pushing back, with program directors holding individual meetings with residents to discourage the effort.

‘We’ll look back and say that this was a bargain.’ Takeda reveals first data from its $4 billion autoimmune disease pill.

The experimental drug, which the drug maker bought earlier this year, completely cleared some patients’ plaque psoriasis in a clinical trial.